Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
ID: PAS-19-316 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 7/18/19 the National Institutes of Health posted grant opportunity PAS-19-316 for Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional).
The grant will be issued under grant program 93.866 Aging Research.
Timing
Posted Date
July 18, 2019, 12:00 a.m. EDT
Closing Date
Sept. 6, 2022, 12:00 a.m. EDT Past Due
Last Updated
July 18, 2019, 12:47 p.m. EDT
Version
1
Archive Date
Oct. 12, 2022
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405
Additional Information Site